Anti-tolerance drugs seem neglected, tractable, and scalable. We’ve done some shallow investigation at QRI and think it is pretty promising. Have been keeping it as a bullet point as we ask around in funding and academic circles. It’s an area that could use a dedicated effort for sure.
Anti-tolerance drugs seem neglected, tractable, and scalable. We’ve done some shallow investigation at QRI and think it is pretty promising. Have been keeping it as a bullet point as we ask around in funding and academic circles. It’s an area that could use a dedicated effort for sure.